METHODS OF TREATING TUMORS

The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-L1 antibody. In some aspects, the pharmaceutical compositions are formulated for subcutaneous delivery. In some aspects, the pharmaceutical compositions further comprise an endoglycosidase hydrolase en...

Full description

Saved in:
Bibliographic Details
Main Authors KHOSSRAVI, Mehrnaz, MURTHY, Bindu Purnima, ROY, Amit, MANTRI, Rao Venkatramana, BELLO, Akintunde, HABY, Thomas Arthur, ZHAO, Xiaochen, HART, Scott Aaron, HUANG, Masano, SANGHAVI, Kinjal, ARAS, Urvi Ashish, VEZINA, Heather Elizabeth
Format Patent
LanguageEnglish
Published 01.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-L1 antibody. In some aspects, the pharmaceutical compositions are formulated for subcutaneous delivery. In some aspects, the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering a pharmaceutical composition comprising an anti-PD-1 antibody or an anti-PD-L1 antibody.
Bibliography:Application Number: US202418423089